Director Robert Langer sold $64K of Rubius Therapeutics, Inc.

Sold$63,875

$8.52Price

7,500Shares

−100%Stake

What RUBY did after the filing

Prices for RUBY after this filing aren't in yet.

Traded Mon, Oct 14. Filed Thu, Oct 17, 2:01 AM ET, before the open. Not investment advice.